Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial.
about
Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort studyTiotropium formulations and safety: a network meta-analysisResponse to Wise et al. (Tiotropium safety in real life populations).Tiotropium safety in 'real-world' populations: Response to Schmiedl, et al. in the British Journal of Clinical PharmacologyWhere to start when treating COPD?
P2860
Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety and efficacy of tiotrop ...... analysis of the TIOSPIR trial.
@ast
Safety and efficacy of tiotrop ...... analysis of the TIOSPIR trial.
@en
type
label
Safety and efficacy of tiotrop ...... analysis of the TIOSPIR trial.
@ast
Safety and efficacy of tiotrop ...... analysis of the TIOSPIR trial.
@en
prefLabel
Safety and efficacy of tiotrop ...... analysis of the TIOSPIR trial.
@ast
Safety and efficacy of tiotrop ...... analysis of the TIOSPIR trial.
@en
P2093
P2860
P356
P1476
Safety and efficacy of tiotrop ...... analysis of the TIOSPIR trial.
@en
P2093
Achim Müller
Andy Fowler
Daniel Dusser
Norbert Metzdorf
Peter M A Calverley
Robert Wise
Ronald Dahl
P2860
P356
10.1038/NPJPCRM.2015.67
P577
2015-11-05T00:00:00Z